{"title":"[4例胰腺癌化疗病理完全缓解]。","authors":"Masanori Akashi, Kazuaki Hashimoto, Ryuta Midorikawa, Shogo Fukutomi, Shoichiro Arai, Yuichi Goto, Hisamune Sakai, Fumihiko Fujita, Toru Hisaka","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>While recent advances in chemotherapy for pancreatic cancer have improved treatment outcomes, pathological complete responses(pCR)remain rare. Here, we present four cases of pancreatic cancer in which a pCR was achieved following chemotherapy. Three cases were classified as borderline resectable and one was resectable. Two patients received gemcitabine+nab-paclitaxel, 1 received mFOLFIRINOX, and one received gemcitabine+S-1 therapy. Histopathological examination after resection revealed only fibrosis and scarring. No tumor cells were found in any of these cases, leading to diagnoses of pCR. Two of the 4 patients survived without recurrence for a long time. The other 2 patients experienced recurrence, one of whom died 8 months after surgery.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 8","pages":"604-606"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Pathological Complete Response to Chemotherapy in Four Cases of Pancreatic Cancer].\",\"authors\":\"Masanori Akashi, Kazuaki Hashimoto, Ryuta Midorikawa, Shogo Fukutomi, Shoichiro Arai, Yuichi Goto, Hisamune Sakai, Fumihiko Fujita, Toru Hisaka\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>While recent advances in chemotherapy for pancreatic cancer have improved treatment outcomes, pathological complete responses(pCR)remain rare. Here, we present four cases of pancreatic cancer in which a pCR was achieved following chemotherapy. Three cases were classified as borderline resectable and one was resectable. Two patients received gemcitabine+nab-paclitaxel, 1 received mFOLFIRINOX, and one received gemcitabine+S-1 therapy. Histopathological examination after resection revealed only fibrosis and scarring. No tumor cells were found in any of these cases, leading to diagnoses of pCR. Two of the 4 patients survived without recurrence for a long time. The other 2 patients experienced recurrence, one of whom died 8 months after surgery.</p>\",\"PeriodicalId\":35588,\"journal\":{\"name\":\"Japanese Journal of Cancer and Chemotherapy\",\"volume\":\"52 8\",\"pages\":\"604-606\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Cancer and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Pathological Complete Response to Chemotherapy in Four Cases of Pancreatic Cancer].
While recent advances in chemotherapy for pancreatic cancer have improved treatment outcomes, pathological complete responses(pCR)remain rare. Here, we present four cases of pancreatic cancer in which a pCR was achieved following chemotherapy. Three cases were classified as borderline resectable and one was resectable. Two patients received gemcitabine+nab-paclitaxel, 1 received mFOLFIRINOX, and one received gemcitabine+S-1 therapy. Histopathological examination after resection revealed only fibrosis and scarring. No tumor cells were found in any of these cases, leading to diagnoses of pCR. Two of the 4 patients survived without recurrence for a long time. The other 2 patients experienced recurrence, one of whom died 8 months after surgery.